Antibiotic Induced Articles & Analysis
4 news found
"Selux's combination of unparalleled time to results and antibiotic test menu, together with its high throughput, will impact patient care and preserve the efficacy of critical antibiotics. ...
MV Biotherapeutics SA (from now on “MV Bio”), a Swiss microbiome biotherapeutics company and Malcisbo AG (from now on “Malcisbo”), a Swiss company developing carbohydrate-based vaccines are proud to announce a collaboration after winning an Innosuisse grant. Malcisbo and MV Bio have previously signed a contract, which gives Malcisbo the exclusive right to use MV Bio ...
ApyraMed® is a live biotherapeutic that has been validated in pre-clinical studies as an enhancer of immune checkpoint blockade in cancer immunotherapy and as a modulator of antibiotic-induced dysbiosis. Research experiments and preclinical trials are performed in the research lab hosted at IRB. ...
MV BioTherapeutics participated for the first time to the international event Bio Digital 2020 presenting the company, the pipeline to over 50 companies. “We weren’t sure about the potential success when we applied to the Swiss Pavillon with the sponsoring of Innosuisse” confirms Dr. Fabio Grassi, founder and chairman. “The support we got from Switzerland Global ...